Office of Technology Commercialization

Seleem, Mohamed

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Selective Therapeutic for C. diff Infection
2018-RAMA-68247
  1. Pharmaceuticals
Ramachandran, P V
New Drug Candidate for Methicillin-Resistant Staphylococcus Aureus Bacterial Infection and Other Drug Resistant Bacteria
2020-RAMA-68859
  1. Pharmaceuticals
  2. Chemistry and Chemical Analysis
Ramachandran, P V
Antimicrobial Peptides Targeting Intracellular Bacteria
2019-CHMI-68405
  1. Chemistry and Chemical Analysis
Chmielewski, Jean Anne
Anti-bacterial Compounds to Treat Neisseria gonorrhoeae Infections
2020-RAMA-68860
  1. Pharmaceuticals
Ramachandran, P V
Novel Therapeutic for Antibiotic Resistant Bacteria
2018-CHMI-68009
  1. Pharmaceuticals
Chmielewski, Jean Anne
Repurposed Drug for Clostridium Difficile Infection
2018-SELE-68251
  1. Pharmaceuticals
  2. Medical/Health
Seleem, Mohamed
Carbonic Anhydrase Inhibitors as Treatment for Gonorrhea
2020-FLAH-68832
  1. Pharmaceuticals
  2. Medical/Health
Flaherty, Daniel P
Selective Antibiotics for Highly Resistant Enterococcus
2019-FLAH-68419
  1. Pharmaceuticals
Flaherty, Daniel P
Antibacterial Agents Against Methicillin- and Vancomycin-Resistant Bacteria
2018-SINT-68199
  1. Biotechnology
  2. Medical/Health
Sintim, Herman O
Second Generation Phenylthiazole Antibiotics for Treatment of MRSA
2016-CUSH-67515
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Cushman, Mark
Compounds with Promising Antibacterial and Antifungal Activity for New Therapeutic Development
2017-DAI-67879
  1. Chemistry and Chemical Analysis
  2. Medical/Health
Dai, Mingji
Novel Aryl Isonitrile Antimicrobials Active Against Clinically Important Bacterial Strains
2015-DAI-67104
  1. Pharmaceuticals
  2. Medical/Health
Dai, Mingji
Nonantimicrobial Used Against Bacterial Infections
2015-SELE-67097
  1. Pharmaceuticals
Seleem, Mohamed
Antimicrobial Activity of Substituted Thiazoles Against MRSA
2013-CUSH-66348
  1. Medical/Health
Cushman, Mark

Details

Dr. Mohamed Seleem is an Associate Professor of Veterinary Microbiology at Purdue University'. He received his MS and DVM from Assiut University and his Ph.D. from Virginia Tech. Dr. Saleem received the 2014 AgSEED award, the 2014 Zoetis Distinguished Teaching Award, and the 2015 Zoetis Award for Research Excellence. Dr. Seleem's research interests include drug repurposing methods to test if drugs already approved by the Federal Drug Administration (FDA) can have an effect on bacterial and fungal infections and lessen the length of the drug development process, saving years of expensive research.

For additional information, visit Dr. Seleem's Purdue website: https://vet.purdue.edu/directory/person.php?id=91